BCN-Carbamate-PEG2-Bromide: Preparation & Bioconjugation Protocol

BCN-carbamate-PEG2-Bromide is a bifunctional bioorthogonal linker combining a strained bicyclo[6.1.0]nonyne (BCN) moiety for inverse electron-demand Diels-Alder (IEDDA) tetrazine ligation with a terminal alkyl bromide for nucleophilic alkylation, bridged by a two-unit polyethylene glycol (PEG2) spacer to enhance aqueous solubility and reduce steric hindrance.

SKU

E1529510

Reactive Groups

BCN (IEDDA/tetrazine ligation) and alkyl bromide (nucleophilic alkylation)

Spacer

PEG2 (two ethylene glycol units) for improved aqueous solubility

Reaction Type

Strain-promoted inverse electron-demand Diels-Alder cycloaddition; SN2 alkylation

Recommended Storage

Store at −20 °C, protected from light and moisture; desiccate under inert gas

Typical Solvents

DMSO, DMF, or acetonitrile (anhydrous); dilute into aqueous buffer just before use

Principle and Reagent Overview

BCN-carbamate-PEG2-Bromide (SKU E1529510) is a heterobifunctional crosslinker designed for sequential or orthogonal bioconjugation strategies. The bicyclo[6.1.0]nonyne (BCN) handle participates in rapid, catalyst-free inverse electron-demand Diels-Alder (IEDDA) reactions with tetrazine-bearing partners, forming a stable dihydropyridazine adduct. This reaction is highly selective and proceeds efficiently under physiological conditions, making it suitable for cell-surface labeling, antibody–drug conjugate (ADC) synthesis, and live-cell imaging.

The alkyl bromide terminus serves as an electrophilic handle for SN2 alkylation of thiol groups (e.g., cysteine residues), amines under forcing conditions, or other nucleophiles. The carbamate linkage connecting BCN to the PEG2 chain provides moderate hydrolytic stability under physiological pH. The PEG2 spacer minimizes steric clash between conjugated partners and improves the overall aqueous compatibility of the linker.

Materials and Equipment

• BCN-carbamate-PEG2-Bromide (E1529510), Aladdin Scientific
• Anhydrous DMSO or DMF (for stock preparation)
• Phosphate-buffered saline (PBS, pH 7.2–7.4) or other aqueous reaction buffer
• Target biomolecule bearing a tetrazine group (for BCN ligation) or a free thiol/nucleophile (for alkyl bromide reaction)
• Microcentrifuge tubes (1.5 mL, low-protein-binding recommended)
• Analytical balance and micropipettes
• Vortex mixer and benchtop microcentrifuge
• Inert gas source (argon or nitrogen) for stock aliquoting
• −20 °C freezer for storage
• UV-Vis spectrophotometer or LC-MS for reaction monitoring (optional but recommended)

Step-by-Step Protocol

1. Stock Solution Preparation

1. Allow the reagent vial to equilibrate to room temperature inside a desiccator before opening to prevent condensation.
2. Dissolve BCN-carbamate-PEG2-Bromide in anhydrous DMSO or DMF to prepare a stock solution (recommended 10–50 mM). Vortex briefly until fully dissolved.
3. Aliquot the stock into single-use volumes under inert gas (argon or nitrogen) to minimize moisture exposure. Seal aliquots and store at −20 °C.

2. BCN–Tetrazine IEDDA Ligation

1. Prepare the tetrazine-functionalized biomolecule in the appropriate aqueous buffer (e.g., PBS, pH 7.2–7.4).
2. Add BCN-carbamate-PEG2-Bromide stock solution to the tetrazine-partner solution to achieve a molar ratio of 1.5–5 equivalents of BCN reagent relative to the tetrazine substrate. Keep the organic co-solvent content ≤10% (v/v).
3. React at room temperature for 30–120 minutes with gentle mixing. Monitor conversion by LC-MS or analytical HPLC.
4. Purify the conjugate by size-exclusion chromatography, dialysis, or spin filtration to remove excess linker.

3. Alkyl Bromide Alkylation (Thiol Targeting)

1. Reduce disulfide bonds in the target protein if necessary (e.g., with TCEP or DTT), then remove the reducing agent by desalting.
2. Dissolve or dilute BCN-carbamate-PEG2-Bromide to the desired working concentration in degassed reaction buffer (pH 7.0–8.0).
3. Add the linker at 2–10 equivalents relative to free thiol. React at room temperature for 1–4 hours or at 4 °C overnight with gentle agitation.
4. Quench unreacted alkyl bromide by adding excess 2-mercaptoethanol or cysteine, then purify the product.

4. Sequential Dual Functionalization

For dual-labeling or branched conjugation, perform the alkylation step first (thiol alkylation is typically slower and requires more controlled conditions), purify the intermediate, then execute the BCN–tetrazine IEDDA ligation in the second step to exploit its superior speed and selectivity.

Troubleshooting and Tips

• Low conjugation yield: Verify that the tetrazine partner or thiol nucleophile is not oxidized or degraded. Increase equivalents of BCN-carbamate-PEG2-Bromide and ensure inert atmosphere during reaction setup.
• Reagent precipitation in aqueous buffer: Pre-dilute the DMSO stock gradually into buffer; do not exceed 10% organic co-solvent. Consider warming the buffer slightly (up to 37 °C) to improve solubility.
• Hydrolysis of alkyl bromide: Prepare working solutions fresh. Avoid prolonged storage of aqueous dilutions; use within 1–2 hours of preparation.
• Carbamate instability: Avoid strongly acidic or basic conditions (pH <5 or >9) to prevent carbamate hydrolysis and BCN release.
• Non-specific labeling: Reduce excess linker equivalents and optimize reaction time; thorough post-reaction purification is essential.
• LC-MS confirmation: Confirm conjugate mass by LC-MS. Expected mass shift corresponds to the molecular weight of BCN-carbamate-PEG2-Bromide minus HBr (for thiol alkylation) or minus N2 and gain of dihydropyridazine ring (for tetrazine ligation).

Safety and Handling

BCN-carbamate-PEG2-Bromide contains an alkyl bromide moiety, which is a mild alkylating agent and potential irritant. Handle with appropriate personal protective equipment (PPE) including nitrile gloves, safety glasses, and a laboratory coat. Work in a well-ventilated area or under a fume hood when handling concentrated stock solutions or organic solvent preparations.

Dispose of waste containing this compound according to institutional and local regulations for halogenated organic waste. Consult the Safety Data Sheet (SDS) for full hazard information before use. Do not allow the compound to come into contact with skin or mucous membranes. In case of accidental exposure, flush with copious water and seek medical attention if necessary.

Frequently asked questions

What solvents are compatible with BCN-carbamate-PEG2-Bromide for stock preparation?

Anhydrous DMSO and DMF are the recommended solvents for preparing concentrated stock solutions. Acetonitrile may also be used. Avoid protic solvents such as water or alcohols for stock preparation, as the alkyl bromide may hydrolyze over time. Dilute into aqueous buffer immediately before use and keep the organic co-solvent below 10% (v/v).

Can the BCN and alkyl bromide groups react orthogonally in the same reaction vessel?

Yes, BCN reacts selectively with tetrazines via IEDDA cycloaddition, while the alkyl bromide reacts with thiols or other nucleophiles via SN2 substitution. These two mechanisms are largely orthogonal under mild aqueous conditions. However, to maximize control over each conjugation step and minimize side reactions, a sequential two-step approach—alkylation first, then IEDDA ligation—is generally recommended.

How should I store BCN-carbamate-PEG2-Bromide to maximize shelf life?

Store the compound as a dry solid at −20 °C in a sealed vial under inert gas (argon or nitrogen), protected from light and moisture. Prepare single-use aliquots of stock solutions to avoid repeated freeze-thaw cycles. Once dissolved, aqueous dilutions should be used immediately and not stored.

What is the expected product of BCN reacting with a tetrazine-labeled antibody?

The BCN moiety reacts with the tetrazine group via inverse electron-demand Diels-Alder cycloaddition followed by retro-[4+2] elimination of nitrogen gas, yielding a stable covalent dihydropyridazine linkage between the linker and the antibody. This bond is considered irreversible under physiological conditions and is stable to common bioconjugation workup conditions.

Is BCN-carbamate-PEG2-Bromide suitable for live-cell labeling experiments?

The BCN moiety is well-established for bioorthogonal live-cell labeling via tetrazine ligation, as the IEDDA reaction is fast and highly selective under physiological conditions. However, the alkyl bromide terminus is a mild alkylating agent and may exhibit some cytotoxicity or non-specific reactivity at higher concentrations. Optimize the working concentration carefully and validate cell viability when using this reagent in live-cell contexts.

References

1. Blackman, M. L.; Royzen, M.; Fox, J. M. Tetrazine ligation: fast bioconjugation based on inverse-electron-demand Diels-Alder reactivity. J. Am. Chem. Soc. 2008, 130, 13518–13519. doi:10.1021/ja8053805
2. Dommerholt, J.; Schmidt, S.; Temming, R.; Hendriks, L. J. A.; Rutjes, F. P. J. T.; van Hest, J. C. M.; Lefeber, D. J.; Friedl, P.; van Delft, F. L. Readily accessible bicyclononynes for bioorthogonal labeling and three-dimensional imaging of living cells. Angew. Chem. Int. Ed. 2010, 49, 9422–9425. doi:10.1002/anie.201003761
3. Oliveira, B. L.; Guo, Z.; Bernardes, G. J. L. Inverse electron demand Diels-Alder reactions in chemical biology. Chem. Soc. Rev. 2017, 46, 4895–4950. doi:10.1039/C7CS00184C

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.